Photo from wikipedia
Sarcopenia is commonly observed in patients with advanced‐stage epithelial ovarian cancer (EOC). However, the effect of body composition changes—during primary debulking surgery (PDS) and adjuvant platinum‐based chemotherapy—on outcomes of patients… Click to show full abstract
Sarcopenia is commonly observed in patients with advanced‐stage epithelial ovarian cancer (EOC). However, the effect of body composition changes—during primary debulking surgery (PDS) and adjuvant platinum‐based chemotherapy—on outcomes of patients with advanced‐stage EOC is unknown. This study aimed to evaluate the association between body composition changes and outcomes of patients with stage III EOC treated with PDS and adjuvant platinum‐based chemotherapy.
Keywords:
debulking surgery;
ovarian cancer;
advanced stage;
primary debulking
Journal Title: Journal of Cachexia, Sarcopenia and Muscle
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Cachexia, Sarcopenia and Muscle
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!